ENO1 Acts as a Prognostic Biomarker Candidate and Promotes Tumor Growth and Migration Ability Through the Regulation of Rab1A in Colorectal Cancer

References

• Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2 ):104–117. doi:10.3322/caac.2122024639052
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1 ):7–34. doi:10.3322/caac.2155130620402
   PubMed Web of Science ®Google Scholar
• Anemone A, Consolino L, Conti L, et al. In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging. Int J Oncol. 2017;51(2 ):498–506. doi:10.3892/ijo.2017.402928714513
   PubMed Web of Science ®Google Scholar
• Zhao M, Liu Q, Gong Y, et al. GSH-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment. Cell Cycle. 2016;15(8 ):1125–1133. doi:10.1080/15384101.2016.115837426950675
   PubMed Web of Science ®Google Scholar
• Jin S, DiPaola RS, Mathew R, White E. Metabolic catastrophe as a means to cancer cell death. J Cell Scie. 2007;120(Pt 3 ):379–383. doi:10.1242/jcs.03349
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016;23(1 ):27–47. doi:10.1016/j.cmet.2015.12.00626771115
   PubMed Web of Science ®Google Scholar
• Kang HJ, Jung SK, Kim SJ, Chung SJ. Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme. Acta Crystallogr D Biol Crystallogr. 2008;64(Pt 6 ):651–657. doi:10.1107/S090744490800856118560153
   PubMedGoogle Scholar
• Zhu X, Miao X, Wu Y, et al. ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in Non-Hodgkin’s Lymphomas. Exp Cell Res. 2015;335(2 ):216–223. doi:10.1016/j.yexcr.2015.05.02026024773
   PubMed Web of Science ®Google Scholar
• Bae S, Kim H, Lee N, et al. α-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis. J Immunol. 2012;189(1 ):365–372. doi:10.4049/jimmunol.110207322623332
   PubMed Web of Science ®Google Scholar
• Gao J, Zhao R, Xue Y, et al. Role of enolase-1 in response to hypoxia in breast cancer: exploring the mechanisms of action. Oncol Rep. 2013;29(4 ):1322–1332. doi:10.3892/or.2013.226923381546
   PubMed Web of Science ®Google Scholar
• Tu SH, Chang CC, Chen CS, et al. Increased expression of enolase alpha in human breast cancer confers tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat. 2010;121(3 ):539–553. doi:10.1007/s10549-009-0492-019655245
   PubMed Web of Science ®Google Scholar
• Tsai ST, Chien IH, Shen WH, et al. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. Eur J Cancer. 2010;46(9 ):1712–1723. doi:10.1016/j.ejca.2010.03.01820435467
   PubMed Web of Science ®Google Scholar
• Pernemalm M, De Petris L, Branca RM, et al. Quantitative proteomics profiling of primary lung adenocarcinoma tumors reveals functional perturbations in tumor metabolism. J Proteome Res. 2013;12(9 ):3934–3943. doi:10.1021/pr400209623902561
   PubMed Web of Science ®Google Scholar
• Duijvesz D, Burnum-Johnson KE, Gritsenko MA, et al. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. PLoS One. 2013;8(12 ):e82589. doi:10.1371/journal.pone.008258924391718
   PubMed Web of Science ®Google Scholar
• Bai Z, Ye Y, Liang B, et al. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer. Int J Oncol. 2011;38(2 ):375–383. doi:10.3892/ijo.2010.87321165559
   PubMed Web of Science ®Google Scholar
• Zhan P, Zhao S, Yan H, et al. alpha-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer. Mol Carcinog. 2017;56(5 ):1427–1437. doi:10.1002/mc.2260327996156
   PubMed Web of Science ®Google Scholar
• Thomas JD, Zhang YJ, Wei YH, et al. Rab1A is an mTORC1 activator and a colorectal oncogene. Cancer Cell. 2014;26(5 ):754–769. doi:10.1016/j.ccell.2014.09.00825446900
   PubMed Web of Science ®Google Scholar
• Wang ZK, Cheng ZW, Chen SJ, et al. Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer. Eur Rev Med Pharmacol Sci. 2018;22(14 ):4509–4517. doi:10.26355/eurrev_201807_1550530058685
   PubMed Web of Science ®Google Scholar
• Cheng Z, Shao X, Xu M, et al. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer. Oncol Rep. 2019;41(5 ):2717–2728. doi:10.3892/or.2019.707130896866
   PubMed Web of Science ®Google Scholar
• Shao X, Kuai X, Pang Z, et al. Correlation of Gli1 and HER2 expression in gastric cancer: identification of novel target. Sci Rep. 2018;8(1 ):397. doi:10.1038/s41598-017-17435-629321573
   PubMedGoogle Scholar
• Bak Y, Kwon T, Bak IS, Hong J, Yu DY, Yoon DY. IL-32theta inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer. Oncotarget. 2016;7(6 ):7307–7317. doi:10.18632/oncotarget.700726824417
   PubMedGoogle Scholar
• Zhang Z, Dong X, Yang X, et al. Expression and clinical significance of absent in melanoma 2 in colorectal cancer. Biomed Pharmacother. 2017;94:843–849. doi:10.1016/j.biopha.2017.07.16128802238
   PubMed Web of Science ®Google Scholar
• Sun L, Lu T, Tian K, et al. Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway. Eur J Pharmacol. 2019;845:8–15. doi:10.1016/j.ejphar.2018.12.03530582908
   PubMed Web of Science ®Google Scholar
• Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17(4 ):351–359. doi:10.1038/ncb312425774832
   PubMed Web of Science ®Google Scholar
• Yu L, Shi J, Cheng S, et al. Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells. Mol Endocrinol. 2012;26(9 ):1521–1530. doi:10.1210/me.2012-100622734040
   PubMedGoogle Scholar
• Song Y, Luo Q, Long H, et al. Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma. Mol Cancer. 2014;13:65. doi:10.1186/1476-4598-13-6524650096
   PubMed Web of Science ®Google Scholar
• Yang J, Zhou M, Zhao R, et al. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis. J Proteomics. 2014;109:162–175. doi:10.1016/j.jprot.2014.06.02524998431
   PubMed Web of Science ®Google Scholar
• Cappello P, Rolla S, Chiarle R, et al. Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. Gastroenterology. 2013;144(5 ):1098–1106. doi:10.1053/j.gastro.2013.01.02023333712
   PubMed Web of Science ®Google Scholar
• Takashima M, Kuramitsu Y, Yokoyama Y, et al. Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics. 2005;5(6 ):1686–1692. doi:10.1002/pmic.20040102215800975
   PubMed Web of Science ®Google Scholar
• Liu YQ, Huang ZG, Li GN, et al. Effects of alpha-enolase (ENO1) over-expression on malignant biological behaviors of AGS cells. Int J Clin Exp Med. 2015;8(1 ):231–239.25784992
   PubMed Web of Science ®Google Scholar
• Qiao H, Wang Y, Zhu B, et al. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival. J Cell Biochem. 2019. doi:10.1002/jcb.29179
   Web of Science ®Google Scholar